Why INSM Stock Is Advancing Today
Drug maker Insmed (INSM) is rising 6% today after it released on Friday afternoon its estimate of the revenue generated by its Arikayce drug in 2024.
Insmed Inc (INSM)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Darwin Global Management Abhishek Trehan | 10,497,277 | $766,301,221 | +197% | 62.31% |
| 2. | Baker Bros. Advisors Julian Baker And Felix Baker | 4,415,918 | $322,362,014 | +24% | 3.34% |
| 3. | 71,505,000 | $164,338,733 | +64% | 0.14% | |
| 4. | 62,024,000 | $142,283,056 | +83% | 3.87% | |
| 5. | Palo Alto Investors William Leland Edwards | 1,940,993 | $141,692,489 | -10% | 18.4% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $19.29 | 10,000 | Director | 10,000 | 2023-05-15 | Filing | |
| $19.29 | 10,000 | Director | 298,615 | 2023-05-15 | Filing | |
| $17.70 | 10,000 | Director | 15,900 | 2022-11-01 | Filing | |
| $17.53 | 20,000 | Director | 281,021 | 2022-10-31 | Filing | |
| $17.69 | 45,000 | Director | 98,265 | 2022-10-31 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $68.72 | 1,384 | Officer | 100,165 | 2025-01-14 | Filing | |
| $68.72 | 1,457 | Officer | 146,082 | 2025-01-14 | Filing | |
| $68.72 | 872 | Officer | 97,083 | 2025-01-14 | Filing | |
| $71.01 | 631 | Officer, Director | 233,924 | 2025-01-15 | Filing | |
| $70.31 | 4,700 | Officer, Director | 234,555 | 2025-01-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 14,125,521 | $437,749,895 | 0% | |
| 2. | 11,492,282 | $356,145,819 | 0% | |
| 3. | 5,929,933 | $183,768,624 | 0% | |
| 4. | 5,091,614 | $157,789,126 | 0.01% | |
| 5. | 4,651,492 | $144,150,000 | 0.16% |
News See All
12 Best Multibagger Stocks to Buy Right Now
The US equities continued their upward movement in 2024 and fueled the S&P 500 to record highs.
10 Best Performing Biotech Stocks in 2024
The biotechnology sector is expanding quickly due to rising demand for novel therapies, advancement in technology, and government assistance.
Should You Invest in Insmed Incorporated (INSM)?
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” third-quarter 2024 investor letter.
10 High Growth Healthcare Stocks to Invest in Now
During lean economic times, investing in healthcare stocks is generally regarded as defensive.
Do You Believe in the Growth Potential of Insmed (INSM)?
Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
Insmed Incorporated (NASDAQ:INSM) Q3 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Jeannie, and I will be your conference operator today.
10 Best Performing NASDAQ Stocks in 2024
Fed's recent cut has resulted in significant outperformance in the tech sector, signaling a positive sentiment among investors.
7 Best Performing Long Term Stocks in 2024
After the latest 50 basis point rate cut by the Federal Reserve, the market has been performing well.
10 Best Performing Stocks in 2024
The Dow Jones Industrial Average has recently made headlines by closing above the 42,000 mark for the first time, a significant milestone that reflects a surge in investor confidence following a substantial...
Billionaire Hedge Funds
